Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Free Cash Flow Generation Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Free Cash Flow Generation Index of -6.78x as of December 2024. Free cash flow of CN¥-163.10 Million represents -7% of operating cash flow (CN¥24.04 Million). Explore reinvestment intensity of Hunan Dajiaweikang Pharmaceutical Indust to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 3 annual periods. For the full cash flow conversion analysis, see Hunan Dajiaweikang Pharmaceutical Indust operating cash flow efficiency.
Annual Free Cash Flow Generation for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year Free Cash Flow Generation Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. Check Hunan Dajiaweikang Pharmaceutical Indust total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.78x | CN¥-163.10 Million | CN¥24.04 Million | CN¥187.14 Million | ▲ +7.8% |
| 2023 | -7.36x | CN¥-199.57 Million | CN¥27.13 Million | CN¥226.70 Million | ▼ -1066.8% |
| 2019 | 0.76x | CN¥103.41 Million | CN¥135.91 Million | CN¥32.50 Million | — |